Navigation Links
Aricept Cleared for Advanced Alzheimer's Treatment

Aricept becomes the first drug to be cleared for treatment of all stages of Alzheimer's, the FDA declared on Oct 13. It had been previously approved// for treating the initial stages of the disease. Eisai shares rose on the announcement upto 6,180 yen on the Tokyo Stock Exchange on Monday morning.

Alzheimer's is a progressive disease with no known cure, which affects brain functions of memory and thinking, leading to the patient's death after much mental deterioration. Doctors are already prescribing Aricept for the advanced stages, so the approval only gives an official status to the drug use.

The other drug being used in the US for treating the advanced stages of the disease is Namenda (Forest Laboratories).

Pfizer and Eisai entered an agreement in 1994 for promoting Aricept, which was discovered and developed by Eisai. This approval is likely to see consolidation of Pfizer's share of the Alzheimer's market. Sales of the drug have been forecast at $1.9 billion through March 2007

'"/>




Page: 1

Related medicine news :

1. Is Aricept, the Alzheimer’s Drug Safe to Use against Vascular Dementia
2. ‘Aricept’ drug gives an Alzheimer’s patient reason to smle
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. The Decks Cleared For HRT - Safe for Menopause Symptoms
5. Doctor Cleared Of Charges of Killing a baby
6. Orissa Villagers Jubilant as Girl Cleared Class X Examination
7. Patent for Seminal RNAi innovation Cleared in Australia
8. Risperdal Cleared By FDA To Treat Autistic Children
9. A Woman Dies Due to Breast Cancer After Being Cleared in the Breast Scan
10. Drug For Iron Overload Cleared
11. Advanced STD programs required
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... The Touchpoint Solution’s new ... after launch. Almost 200 backers pledged more than $25,000 on Kickstarter ... , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, says she feels like ...
(Date:12/6/2016)... ... 06, 2016 , ... Of the variety of ingredients in the food supply, ... contrary to common beliefs that hot dogs include “everything but the oink,” today’s wieners ... Ingredients combined with meat and poultry in a hot dog recipe can add flavor, ...
(Date:12/6/2016)... San Mateo, CA (PRWEB) , ... December 06, ... ... boost for their sports programs have until January 15, 2017 to apply for ... can be found at http://www.calcasathleticsgrant.com . Qualifying schools can receive up ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... is thrilled to formally announce its Not a Moment to Lose fundraising campaign. ... will rally supporters dedicated to declaring victory over cancer. The campaign aims to ...
(Date:12/6/2016)... ... 2016 , ... METTLER TOLEDO has launched its online ... papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user manuals, ... webinars and videos available online, visit the METTLER TOLEDO Expertise Library . ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... announced the presentation of preclinical and manufacturing data that support ... 58 th Annual Meeting of the American Society of ... , from December 3-6, 2016. "We have ... A which we believe is highly competitive, and we remain ...
(Date:12/5/2016)... Dec. 5, 2016  Parallax Health Sciences, Inc. ("Parallax" ... announce that its pharmaceutical business, RoxSan Pharmacy, Inc. has ... coverage in all of the 42 states it is ... Michael Rashti Pharm . D, Pharmacist in Charge ... for our business. Medicare B spending last year came ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. ... the Commercialization of Public Research (the Florida ... funding agreement SegAna, LLC, an Orlando ... of Central Florida. The Florida Institute supports new ... early funding gaps for companies spinning out of Florida-based ...
Breaking Medicine Technology: